108 related articles for article (PubMed ID: 9798411)
1. HER-2/Neu expression as a progression marker in pancreatic intraepithelial neoplasia.
Tomaszewska R; Okoń K; Nowak K; Stachura J
Pol J Pathol; 1998; 49(2):83-92. PubMed ID: 9798411
[TBL] [Abstract][Full Text] [Related]
2. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
Tomaszewska R
Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms.
Day JD; Digiuseppe JA; Yeo C; Lai-Goldman M; Anderson SM; Goodman SN; Kern SE; Hruban RH
Hum Pathol; 1996 Feb; 27(2):119-24. PubMed ID: 8617452
[TBL] [Abstract][Full Text] [Related]
4. Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21(WAF1/CIP1).
Hermanová M; Lukás Z; Nenutil R; Brázdil J; Kroupová I; Kren L; Pazourková M; Růzicka M; Díte P
Neoplasma; 2004; 51(2):77-83. PubMed ID: 15190415
[TBL] [Abstract][Full Text] [Related]
5. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
6. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
7. [Histomorphometric study of normal, atypical and neoplastic pancreatic duct epithelium].
von Streitberg U
Verh Dtsch Ges Pathol; 1990; 74():207-10. PubMed ID: 1708585
[TBL] [Abstract][Full Text] [Related]
8. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
[TBL] [Abstract][Full Text] [Related]
9. [Pancreatic intraepithelial neoplasia in chronic pancreatitis].
Tannapfel A; Witzigmann H; Wittekind C
Zentralbl Chir; 2001 Nov; 126(11):879-83. PubMed ID: 11753797
[TBL] [Abstract][Full Text] [Related]
10. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
[TBL] [Abstract][Full Text] [Related]
11. Role of immunohistochemical identification of Her-2/neu and detection of variability in overexpression in pancreatic carcinoma.
Koka V; Potti A; Koch M; Fraiman G; Mehdi S; Levitt R
Anticancer Res; 2002; 22(3):1593-7. PubMed ID: 12168842
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of the association between the progression of pancreatic ductal lesions and the expression of MUC1, MUC2, MUC5AC, and E-cadherin.
Kigure S
Rinsho Byori; 2006 May; 54(5):447-52. PubMed ID: 16789413
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components.
Sanada Y; Yoshida K; Ohara M; Oeda M; Konishi K; Tsutani Y
Pancreas; 2006 Mar; 32(2):164-70. PubMed ID: 16552336
[TBL] [Abstract][Full Text] [Related]
14. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L
J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
[TBL] [Abstract][Full Text] [Related]
15. AgNORs in duct epithelial lesions in chronic pancreatitis and in pancreas cancer cells.
Cylwik B; Nowak HF; Puchalski Z; Zimnoch L; Dadan J
Hepatogastroenterology; 1998; 45(22):1130-4. PubMed ID: 9756019
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma.
Andea A; Sarkar F; Adsay VN
Mod Pathol; 2003 Oct; 16(10):996-1006. PubMed ID: 14559982
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of expression of molecular biologic factors in intraductal papillary-mucinous tumors of pancreas--diagnostic and biologic significance.
Islam HK; Fujioka Y; Tomidokoro T; Sugiura H; Takahashi T; Kondo S; Katoh H
Hepatogastroenterology; 1999; 46(28):2599-605. PubMed ID: 10522048
[TBL] [Abstract][Full Text] [Related]
18. HER2/neu expression and gene alterations in pancreatic ductal adenocarcinoma: a comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis.
Tsiambas E; Karameris A; Dervenis C; Lazaris AC; Giannakou N; Gerontopoulos K; Patsouris E
JOP; 2006 May; 7(3):283-94. PubMed ID: 16685109
[TBL] [Abstract][Full Text] [Related]
19. Varying grades of epithelial atypia in the pancreatic ducts of humans. Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen.
Furukawa T; Chiba R; Kobari M; Matsuno S; Nagura H; Takahashi T
Arch Pathol Lab Med; 1994 Mar; 118(3):227-34. PubMed ID: 8135625
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry.
Di Palma S; Skálová A; Vanìèek T; Simpson RH; Stárek I; Leivo I
Histopathology; 2005 Feb; 46(2):144-52. PubMed ID: 15693886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
